Clinical trial
A Study of Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18F-DCFPyL
NCT05588128 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18F-DCFPyL
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 21, 2023
- Completion date
- December 31, 2027
- Enrollment
- 350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biochemically recurrent, prostate cancer